23andMe, genetic testing
Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
The genealogy company’s CEO announced over 200 employees will be let go and it will also shutter its drug-development arm. I ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback